- Main
- Analytics
- Market News
- Company news: AstraZeneca’s (AZN) quarterly results beat analysts’ forecasts
Economic news
12.11.2024
Company news: AstraZeneca’s (AZN) quarterly results beat analysts’ forecasts
AstraZeneca (AZN) reported Q3 FY2024 earnings of $2.08 per share (versus $1.73 per share in Q3 FY2023), beating analysts’ consensus estimate of $2.04 per share.
The company’s quarterly revenues amounted to $13.565 bln (+18.0% y/y), beating analysts’ consensus estimate of $13.076 bln.
AZN fell to $64.00 (-1.22%) in pre-market trading.
See also